Ethiopian Lives
-
Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 MonthsDetails
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med
-
Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable SafetyDetails
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med
-
KPM Analytics Expands AI and Software Development Operations to Drive InnovationDetails
The large state-of-the-art facility in Orem,Utah,allows KPM Analytics to expand our Artificial Intelligence and software development utilized across KPM\'s brand portfolio.
-
【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell MalignanciesDetails
NANJING,China and GAITHERSBURG,Md.,Dec. 10,2024--TransThera Sciences (Nanjing),Inc. (the "TransThera"),a clinical demand-oriented,registrational clinical stage biopharmaceutical company focu
-
Solace Unlocks Full Potential of Event-Driven Integration with Introduction of PubSub+ Micro-IntegrationsDetails
Newdecentralized approach to integration makes it easier to get real-time dataflowing between systems across environments,geographies and organizations
-
State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company carries out intelligent upgrading of the power gridDetails
ARTUSH,China,Dec. 11,2024-- Recently,the transformer maintenance personnel of the State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company carried out the installation of current
-
Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer TreatmentDetails
DOVER,Del. and EPALINGES,Switzerland,Dec. 11,2024-- Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecul
-
TPIsoftware Attends Taiwan-Poland MOU Signing for Deepened Collaboration on Space TechnologyDetails
TAIPEI,Dec. 11,2024-- TAIPO Taiwan-Poland Chamber of Commerce and the Polish IoT & AI cluster SINOTAIC have signed a Memorandum of Understanding (MOU) to strengthen collaboration in satellite app
-
PayerMax and Standard Chartered Partner to Navigate the Complexities of Cross-Border PaymentsDetails
SINGAPORE,Dec. 11,2024-- During the recent SingaporeFintech Festival,Wang Hu,Co-founder & President at PayerMax,and Luke Boland,Global Head of Fintech at Standard Chartered,shared on how their co
-
Xinhua Silk Road: Climate investment and financing under spotlight at key conference held in S. China's Guangzhou NanshaDetails
BEIJING,Dec. 11,2024-- Guests from home and abroad shared experiences in climate investment and financing as well as reached consensus on addressing climate change on December 8 as they gathered in Na